168 related articles for article (PubMed ID: 14586381)
1. Label development and the label comprehension study for over-the-counter drugs.
Brass EP; Weintraub M
Clin Pharmacol Ther; 2003 Nov; 74(5):406-12. PubMed ID: 14586381
[No Abstract] [Full Text] [Related]
2. New drug label spells it out simply.
Nordenberg T
FDA Consum; 1999; 33(4):29-32. PubMed ID: 10443179
[No Abstract] [Full Text] [Related]
3. Panel recommends limits on alcohol content of nonprescription products. FDA Over-The-Counter Drugs Advisory Committee.
Am J Hosp Pharm; 1993 Mar; 50(3):400. PubMed ID: 8442445
[No Abstract] [Full Text] [Related]
4. The dangers of self-dosing.
Schultz S
US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369
[No Abstract] [Full Text] [Related]
5. Active ingredient consistency of commercially available glucosamine sulfate products.
Russell AS; Aghazadeh-Habashi A; Jamali F
J Rheumatol; 2002 Nov; 29(11):2407-9. PubMed ID: 12415601
[TBL] [Abstract][Full Text] [Related]
6. New OTC drug facts label.
FDA Consum; 2002; 36(4):35. PubMed ID: 12184303
[No Abstract] [Full Text] [Related]
7. Over-the-counter product line extensions: have we reached the limit yet?
Sansgiry SS
J Am Geriatr Soc; 2004 Jul; 52(7):1223-4. PubMed ID: 15209675
[No Abstract] [Full Text] [Related]
8. Drug packaging.
Doyle DJ
CMAJ; 1997 Mar; 156(6):764-5. PubMed ID: 9084377
[No Abstract] [Full Text] [Related]
9. Changing over-the-counter drugs while retaining the brand name.
Merikangas JR
Ann Intern Med; 1993 Jun; 118(12):988. PubMed ID: 8489122
[No Abstract] [Full Text] [Related]
10. What has been happening with over-the-counter drug regulation.
Stringer S
Food Drug Law J; 1998; 53(4):633-41. PubMed ID: 10557581
[No Abstract] [Full Text] [Related]
11. FDA considers OTC drug labeling reform.
Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
[No Abstract] [Full Text] [Related]
12. Labeling information on nonprescription drug products.
Am Pharm; 1988 Nov; NS28(11):24-5. PubMed ID: 3207092
[No Abstract] [Full Text] [Related]
13. From the Food and Drug Administration.
Nightingale SL
JAMA; 1999 Apr; 281(13):1164. PubMed ID: 10199413
[No Abstract] [Full Text] [Related]
14. FDA drug safety communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection.
Clin Infect Dis; 2014 Feb; 58(3):i-ii. PubMed ID: 24571007
[No Abstract] [Full Text] [Related]
15. [Over the counter drugs should be accompanied with better directions for use].
Salling AL
Sygeplejersken; 1978 Feb; 78(6):9. PubMed ID: 247768
[No Abstract] [Full Text] [Related]
16. Dosing botanical medicines.
Yarnell E
J Herb Pharmacother; 2005; 5(1):73-8. PubMed ID: 16093237
[No Abstract] [Full Text] [Related]
17. An investigative model evaluating how consumers process pictorial information on nonprescription medication labels.
Sansgiry SS; Cady PS
Health Mark Q; 1997; 14(4):71-90. PubMed ID: 10168485
[TBL] [Abstract][Full Text] [Related]
18. OTCs and PPIs what is going on here?
Ryan AJ
Postgrad Med; 1978 Apr; 63(4):19-20. PubMed ID: 634866
[No Abstract] [Full Text] [Related]
19. OTC labeling reform.
J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
[No Abstract] [Full Text] [Related]
20. Secondary pharmaceuticals manufacturing.
Burling JN; Shah PV
Occup Med; 1997; 12(1):29-48. PubMed ID: 9153051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
